Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
EHAB 
Enhabit Inc. (EHAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: EHAB (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $9.38
1 Year Target Price $9.38
| 1 | Strong Buy |
| 0 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.51% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 390.32M USD | Price to earnings Ratio - | 1Y Target Price 9.38 |
Price to earnings Ratio - | 1Y Target Price 9.38 | ||
Volume (30-day avg) 5 | Beta 1.31 | 52 Weeks Range 6.47 - 10.90 | Updated Date 09/16/2025 |
52 Weeks Range 6.47 - 10.90 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.66 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -12.84% | Operating Margin (TTM) 6.28% |
Management Effectiveness
Return on Assets (TTM) 2.61% | Return on Equity (TTM) -20.37% |
Valuation
Trailing PE - | Forward PE 15.87 | Enterprise Value 894633306 | Price to Sales(TTM) 0.38 |
Enterprise Value 894633306 | Price to Sales(TTM) 0.38 | ||
Enterprise Value to Revenue 0.86 | Enterprise Value to EBITDA 14.43 | Shares Outstanding 50690400 | Shares Floating 40188856 |
Shares Outstanding 50690400 | Shares Floating 40188856 | ||
Percent Insiders 3.4 | Percent Institutions 102.87 |
Upturn AI SWOT
Enhabit Inc.
Company Overview
History and Background
Enhabit, Inc. (formerly Encompass Health Home Health & Hospice) was spun off from Encompass Health Corp. in July 2022. It focuses on providing in-home healthcare services.
Core Business Areas
- Home Health: Provides skilled nursing, therapy, and other medical services to patients in their homes.
- Hospice: Offers end-of-life care and support to patients and their families.
Leadership and Structure
The leadership team includes Barbara A. Jacobsmeyer (CEO) and Crissy Carlisle (CFO). The company operates with a geographically distributed network of locations.
Top Products and Market Share
Key Offerings
- Home Health Services: Skilled nursing, physical therapy, occupational therapy, speech therapy, and medical social services provided in patients' homes. Market share is competitive within the fragmented home healthcare market. Competitors include Amedisys, LHC Group, and Brookdale Senior Living.
- Hospice Care: Comprehensive end-of-life care including pain management, emotional support, and spiritual care for patients and their families. Competitors include Amedisys, LHC Group, and smaller regional hospice providers.
Market Dynamics
Industry Overview
The home healthcare and hospice industry is experiencing growth driven by the aging population, increasing prevalence of chronic diseases, and a shift towards value-based care.
Positioning
Enhabit is a large provider of home health and hospice services, benefiting from scale and brand recognition. Its competitive advantage lies in its established network and expertise in managing complex patient needs.
Total Addressable Market (TAM)
The TAM for home health and hospice care is estimated to be in the hundreds of billions of dollars. Enhabit is positioned to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Established brand and reputation
- Large network of locations
- Experienced management team
- Diversified service offerings
Weaknesses
- Exposure to regulatory changes
- Labor shortages in healthcare
- Reliance on government reimbursement
- High competition within the home health and hospice market
Opportunities
- Expanding into new geographic markets
- Acquiring smaller regional providers
- Developing innovative service models
- Leveraging technology to improve care delivery
Threats
- Changes in government reimbursement policies
- Increased competition from other providers
- Rising labor costs
- Economic downturn affecting patient demand
Competitors and Market Share
Key Competitors
- AMED
- LHCG
- FTNT
Competitive Landscape
Enhabit competes with national and regional providers of home health and hospice services. Key competitive factors include service quality, reputation, cost, and geographic reach.
Growth Trajectory and Initiatives
Historical Growth: Focus will be on the growth since separation from Encompass, if available.
Future Projections: Analyst estimates will be the best source for future projections.
Recent Initiatives: Will need to monitor press releases and other reports to identify recent strategic initiatives undertaken by Enhabit Inc.
Summary
Enhabit Inc. is a player in the growing home health and hospice market. Its established network and brand recognition provide a competitive advantage. However, the company faces challenges related to labor shortages and regulatory uncertainty. Strategic initiatives focused on expansion and innovation will be critical for future success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Financial News Outlets
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Enhabit Inc.
Exchange NYSE | Headquaters Dallas, TX, United States | ||
IPO Launch date 2022-07-01 | President, CEO & Director Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 10600 | Website https://www.ehab.com |
Full time employees 10600 | Website https://www.ehab.com | ||
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.